An open-label, prospective study assessing impact on endothelial function after canakinumab treatment in patients with chronic gout
Latest Information Update: 12 Aug 2016
At a glance
- Drugs Canakinumab (Primary)
- Indications Gout
- Focus Pharmacodynamics; Pharmacokinetics
- 12 Aug 2016 New trial record